130 related articles for article (PubMed ID: 785628)
1. Vaccine and Mycostatin in treatment of cryptococcosis of the respiratory tract.
Bemmer AM; Davidson W; Kuttin ES; Zydon Y; Pinto M
Sabouraudia; 1976 Jul; 14(2):171-9. PubMed ID: 785628
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fungal infections with flucytosine.
Harder EJ; Hermans PE
Arch Intern Med; 1975 Feb; 135(2):231-7. PubMed ID: 1096840
[TBL] [Abstract][Full Text] [Related]
3. Antibody immunity and invasive fungal infections.
Casadevall A
Infect Immun; 1995 Nov; 63(11):4211-8. PubMed ID: 7591049
[No Abstract] [Full Text] [Related]
4. [Fungicidal action of decamine and nystatin in respiratory diseases in young children].
Zaglukhinskaia EN; Pershin GN; Milovanova SN; Zarubova AE
Antibiotiki; 1966 Aug; 11(8):750-5. PubMed ID: 5999798
[No Abstract] [Full Text] [Related]
5. Treatment with antifungal vaccines.
Beemer AM; Kuttin ES; Pinto M
Contrib Microbiol Immunol; 1977; 4():136-46. PubMed ID: 342190
[No Abstract] [Full Text] [Related]
6. Preventative and therapeutic vaccines for fungal infections: from concept to implementation.
Deepe GS
Expert Rev Vaccines; 2004 Dec; 3(6):701-9. PubMed ID: 15606355
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.
Pirofski LA
Trends Microbiol; 2001 Sep; 9(9):445-51. PubMed ID: 11553457
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary cryptococcosis: atypical results in the serum test for cryptococcal antigen.
Jenkins C; Breslin AB
Aust N Z J Med; 1982 Oct; 12(5):527-30. PubMed ID: 6758749
[TBL] [Abstract][Full Text] [Related]
9. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
Fromtling RA; Blackstock R; Hall NK; Bulmer GS
Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
[TBL] [Abstract][Full Text] [Related]
10. Innate host defenses against Cryptococcus neoformans.
Hole C; Wormley FL
J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
[TBL] [Abstract][Full Text] [Related]
11. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
Costa AL; Valenti A; Costa G; Calogero F
G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary mycosis.
Kohno S; Koga H
Intern Med; 1993 Dec; 32(12):932-4. PubMed ID: 8204975
[No Abstract] [Full Text] [Related]
13. Pulmonary cryptococcosis: clinical analysis and treatment of 14 cases.
Chou CC; Chen CR; Lee LN; Kuo SH; Luh KT
Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):459-66. PubMed ID: 3625154
[No Abstract] [Full Text] [Related]
14. Cryptococcal interstitial pneumonia: value of antigen determination.
Fisher BD; Armstrong D
N Engl J Med; 1977 Dec; 297(26):1440-1. PubMed ID: 337142
[No Abstract] [Full Text] [Related]
15. Aerosol chemotherapy in bronchopulmonary candidiasis.
Oehling A; Giron M; Subira ML
Respiration; 1975; 32(2):179-84. PubMed ID: 1090988
[TBL] [Abstract][Full Text] [Related]
16. Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.
Anderson DM; Dykstra MA
Mycopathologia; 1984 Jun; 86(3):169-77. PubMed ID: 6382015
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcal lung disease in patients without HIV infection.
Sarosi GA
Chest; 1999 Mar; 115(3):610-1. PubMed ID: 10084461
[No Abstract] [Full Text] [Related]
18. Is Development of a Vaccine against Cryptococcus neoformans Feasible?
Leopold Wager CM; Wormley FL
PLoS Pathog; 2015 Jun; 11(6):e1004843. PubMed ID: 26087178
[No Abstract] [Full Text] [Related]
19. Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.
Reiss E; Cherniak R; Eby R; Kaufman L
Diagn Immunol; 1984; 2(2):109-15. PubMed ID: 6388977
[TBL] [Abstract][Full Text] [Related]
20. Towards a vaccine for Cryptococcus neoformans: principles and caveats.
Datta K; Pirofski LA
FEMS Yeast Res; 2006 Jun; 6(4):525-36. PubMed ID: 16696648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
